UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day

Journal of child and adolescent psychopharmacology, 2023-02, Vol.33 (1), p.14-19

2023

Volltextzugriff (PDF)

The microbiology of Bandji, palm wine of Borassus akeassii from Burkina Faso: identification and genotypic diversity of yeasts, lactic acid and acetic acid bacteria

Journal of applied microbiology, 2012-12, Vol.113 (6), p.1428-1441

2012

Volltextzugriff (PDF)

Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studies

Neuropsychiatric disease and treatment, 2018-01, Vol.14, p.537-546

2018

Volltextzugriff (PDF)

Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD

Drug design, development and therapy, 2021-01, Vol.15, p.2979-2985

2021

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Evaluate the Efficacy and Safety of Amphetamine Extended-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder

The journal of clinical psychiatry, 2022-09, Vol.83 (5)

2022

Volltextzugriff (PDF)

A single-dose, comparative bioavailability study comparing amphetamine extended-release oral suspension with extended-release mixed amphetamine salts capsules

CNS spectrums, 2022-06, Vol.27 (3), p.309-314

2022

Volltextzugriff (PDF)

178 Single-Dose Pharmacokinetics of Amphetamine Extended-Release Tablet Compared with Amphetamine Extended-Release Oral Suspension

CNS spectrums, 2020-04, Vol.25 (2), p.312-313

2020

Volltextzugriff (PDF)

Comparative Bioavailability of Amphetamine Extended-Release Oral Suspension and Extended-Release Mixed Amphetamine Salts

CNS spectrums, 2021-04, Vol.26 (2), p.163-163

2021

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Evaluate the Efficacy and Safety of the Amphetamine Extended-Release Tablet in Adults with Attention-Deficit/Hyperactivity Disorder

CNS spectrums, 2022-04, Vol.27 (2), p.242-243

2022

Volltextzugriff (PDF)

2.18 Single-Dose Pharmacokinetics of Amphetamine Extended-Release Tablet Compared With Amphetamine Extended-Release Oral Suspension

Journal of the American Academy of Child and Adolescent Psychiatry, 2018-10, Vol.57 (10), p.S164-S164

2018

Volltextzugriff (PDF)

Single-Dose Pharmacokinetics of Amphetamine Extended-Release Oral Suspension in Healthy Adults

Journal of attention disorders, 2021-04, Vol.25 (6), p.803-808

2021

Volltextzugriff (PDF)

Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension

CNS spectrums, 2020-12, Vol.25 (6), p.774-781

2020

Volltextzugriff (PDF)

Single-Dose Pharmacokinetics of Amphetamine Extended-Release Oral Suspension (AMPH EROS) in 6–12-Year-Old Children with ADHD

CNS spectrums, 2021-04, Vol.26 (2), p.163-163

2021

Volltextzugriff (PDF)

179 Palatability Assessment of a New Amphetamine Extended-Release Tablet Formulation

CNS spectrums, 2020-04, Vol.25 (2), p.313-313

2020

Volltextzugriff (PDF)

88 The Efficacy and Safety of Amphetamine Extended-Release Oral Suspension (AMPH EROS) in Children with Attention-Deficit/Hyperactivity Disorder

CNS spectrums, 2019-02, Vol.24 (1), p.219-220

2019

Volltextzugriff (PDF)

2.19 Efficacy Measures in an Open-Label Dose-Optimization Study of an Amphetamine Extended-Release Oral Suspension in Children With ADHD

Journal of the American Academy of Child and Adolescent Psychiatry, 2018-10, Vol.57 (10), p.S164-S165

2018

Volltextzugriff (PDF)

Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder

Journal of child and adolescent psychopharmacology, 2019-02, Vol.29 (1), p.2-8

2019

Volltextzugriff (PDF)

Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication

The American journal of psychiatry, 1992-05, Vol.149 (5), p.587-595

1992

Volltextzugriff (PDF)

31 A Modified-Release Drug Delivery Technology Containing Amphetamine-Ion Exchange Complexes

CNS spectrums, 2019-02, Vol.24 (1), p.191-191

2019

Volltextzugriff (PDF)

89 A Novel, Modified-Release Drug Delivery Technology Containing Amphetamine-Ion Exchange Complexes

CNS spectrums, 2019-02, Vol.24 (1), p.220-220

2019

Volltextzugriff (PDF)

32 Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension (AMPH EROS) in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder

CNS spectrums, 2019-02, Vol.24 (1), p.191-192

2019

Volltextzugriff (PDF)

87 Efficacy Measures in an Open-label Dose-Optimization of an Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder

CNS spectrums, 2019-02, Vol.24 (1), p.218-219

2019

Volltextzugriff (PDF)

Ensuring Stakeholder Feedback in the Design and Conduct of Clinical Trials for Rare Diseases: ISCTM Position Paper of the Orphan Disease Working Group

Innovations in clinical neuroscience, 2024-01, Vol.21 (1-3), p.52-60

2024

Volltextzugriff (PDF)

Gender as a risk factor for adverse events to medications

Drugs (New York, N.Y.), 1995-07, Vol.50 (1), p.1-6

1995

Volltextzugriff (PDF)

Use and Value of the 7-Item Binge Eating Disorder Screener in Clinical Practice

Primary care companion for CNS disorders, 2017-06, Vol.19 (3)

2017

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(99)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(74)
Humans
(32)
Physical Sciences
(32)
Life Sciences & Biomedicine
(30)
Physics
(30)
Male
(24)
Psychiatry
(24)
Female
(23)
Adult
(17)
Amphetamines
(17)
Biological And Medical Sciences
(17)
Medical Sciences
(16)
Pharmacology. Drug Treatments
(15)
Technology
(15)
Physics, Fluids & Plasmas
(14)
Attention Deficit Hyperactivity Disorder
(13)
Physics, Applied
(12)
Middle Aged
(11)
Lasers
(10)
Psychology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day

The microbiology of Bandji, palm wine of Borassus akeassii from Burkina Faso: identification and genotypic diversity of yeasts, lactic acid and acetic acid bacteria

Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studies

Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD

Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Evaluate the Efficacy and Safety of Amphetamine Extended-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder

A single-dose, comparative bioavailability study comparing amphetamine extended-release oral suspension with extended-release mixed amphetamine salts capsules

178 Single-Dose Pharmacokinetics of Amphetamine Extended-Release Tablet Compared with Amphetamine Extended-Release Oral Suspension

Comparative Bioavailability of Amphetamine Extended-Release Oral Suspension and Extended-Release Mixed Amphetamine Salts

Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Evaluate the Efficacy and Safety of the Amphetamine Extended-Release Tablet in Adults with Attention-Deficit/Hyperactivity Disorder

2.18 Single-Dose Pharmacokinetics of Amphetamine Extended-Release Tablet Compared With Amphetamine Extended-Release Oral Suspension

Single-Dose Pharmacokinetics of Amphetamine Extended-Release Oral Suspension in Healthy Adults

Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension

Single-Dose Pharmacokinetics of Amphetamine Extended-Release Oral Suspension (AMPH EROS) in 6–12-Year-Old Children with ADHD

179 Palatability Assessment of a New Amphetamine Extended-Release Tablet Formulation

88 The Efficacy and Safety of Amphetamine Extended-Release Oral Suspension (AMPH EROS) in Children with Attention-Deficit/Hyperactivity Disorder

2.19 Efficacy Measures in an Open-Label Dose-Optimization Study of an Amphetamine Extended-Release Oral Suspension in Children With ADHD

Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder

Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication

31 A Modified-Release Drug Delivery Technology Containing Amphetamine-Ion Exchange Complexes

89 A Novel, Modified-Release Drug Delivery Technology Containing Amphetamine-Ion Exchange Complexes

32 Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension (AMPH EROS) in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder

87 Efficacy Measures in an Open-label Dose-Optimization of an Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder

Ensuring Stakeholder Feedback in the Design and Conduct of Clinical Trials for Rare Diseases: ISCTM Position Paper of the Orphan Disease Working Group

Gender as a risk factor for adverse events to medications

Use and Value of the 7-Item Binge Eating Disorder Screener in Clinical Practice

Suchergebnisse filtern